Effectiveness of quality improvement strategies on the management of diabetes: A systematic review and meta-analysis

The Lancet

Volumn 379, Issue 9833, 2012, Pages 2252-2261

  Tricco, Andrea C ^a   Ivers, Noah M ^b   Grimshaw, Jeremy M ^d,e   Moher, David ^d,e   Turner, Lucy ^d   Galipeau, James ^d   Halperin, Ilana ^c   Vachon, Brigitte ^d,f   Ramsay, Tim ^d,e   Manns, Braden ^g   Tonelli, Marcello ^g   Shojania, Kaveh ^h  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK MANAGEMENT; SCREENING; SMOKING CESSATION; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TOTAL QUALITY MANAGEMENT;

EID: 84862302106     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60480-2     Document Type: Article

References (27)

1. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33 (suppl 1): S11-61.
2. Braga M, Casanova A, Teoh H, et al. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. Can J Cardiol 2010; 26: 297-302.
3. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002; 136: 565-74.
4. McFarlane SI, Jacober SJ, Winer N, et al. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 2002; 25: 718-23.
5. Narayan KM, Benjamin E, Gregg EW, Norris SL, Engelgau MM. Diabetes translation research: where are we and where do we want to be? Ann Intern Med 2004; 140: 958-63.
6. Kogan AJ. Overcoming obstacles to effective care of type 2 diabetes. Am J Manag Care 2009; 15 (9 suppl): S255-62.
7. Simpson SH, Corabian P, Jacobs P, Johnson JA. The cost of major comorbidity in people with diabetes mellitus. CMAJ 2003; 168: 1661-67.
8. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006; 296: 427-40.
9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
10. Shojania KG, Ranji SR, Shaw LK, et al. Diabetes Mellitus Care-vol 2. In: Shojania KG, McDonald KM, Wachter RM, Owens DK. Closing the quality gap: a critical analysis of quality improvement strategies-technical review 9. Rockville, MD: Agency for Healthcare Research and Quality, 2004.
11. Sampson M, McGowan J, Cogo E, Grimshaw J, Moher D, Lefebvre C. An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol 2009; 62: 944-52.
12. Armstrong R, Waters E, Doyle J, eds. Chapter 21: reviews in public health and health promotion. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0. Oxford: The Cochrane Collaboration, 2011.
13. Cochrane Effective Practice and Organisation of Care Group. Risk of bias-EPOC specific. http://epoc.cochrane.org/epoc-authorresources (accessed July 1, 2009).
14. Rao JN, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics 1992; 48: 577-85.
15. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0. Oxford: The Cochrane Collaboration, 2011.
16. Kerry SM, Bland JM. The intracluster correlation coefficient in cluster randomisation. BMJ 1998; 316: 1455.
17. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Stat Med 2002; 21: 2971-80.
18. Campbell M, Grimshaw J, Steen N. Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action). J Health Serv Res Policy 2000; 5: 12-16.
19. Cook C. Julia H Littell, Jacqueline Corcoran, Vijayan Pillai, Systematic reviews and meta-analysis (2008) Oxford University Press, New York 202 ISBN: 978-0-19-532654-3. Child Youth Serv Rev 2009; 31: 495-96.
20. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 2006; 59: 7-10.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
22. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
23. Allemann S, Houriet C, Diem P, Stettler C. Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Curr Med Res Opin 2009; 25: 2903-13.
24. Duke SA, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2009; 1: CD005268.
25. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.
26. van Bokhoven MA, Kok G, van der Weijden T. Designing a quality improvement intervention: a systematic approach. Qual Saf Health Care 2003; 12: 215-20.
27. Michie S, Fixsen D, Grimshaw JM, Eccles MP. Specifying and reporting complex behaviour change interventions: the need for a scientific method. Implement Sci 2009; 4: 40.